Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

TerminatedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

February 24, 2025

Study Completion Date

February 24, 2025

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

Monomethyl Fumarate

95 mg oral capsule, 190 mg (2 x 95 mg) twice daily

Trial Locations (10)

20817

Comprehensive Neurology Clinics of Bethesda Mid-Atlantic Epilepsy and Sleep Center, Bethesda

21061

Maryland Center for Neurology and Sleep, Glen Burnie

53226

Medical College of Wisconsin, Milwaukee

85032

Center for Neurology and Spine, Phoenix

85253

Perseverance Research Center, LLC, Scottsdale

85258

Clinical Endpoints, Scottsdale

85297

Gilbert Neurology, Gilbert

90048

Regina Berkovich MD PhD Inc., West Hollywood

07666

Holy Name Medical Center, Teaneck

Unknown

Caribbean Center for Clinical Research/San Juan MS Center, San Juan

Sponsors
All Listed Sponsors
lead

Banner Life Sciences LLC

INDUSTRY